Amgen has reported encouraging mid-stage results for its olpasiran candidate for reducing lipoprotein(a) – a risk factor for atherosclerotic cardiovascular disease – and now plans to move ahead ...

Abstract: In response to the issues of multi-auxiliary components and low device utilization, as well as high common-mode voltage (CMV) in the current three-phase three-level neutral-point-clamped ...

Abstract: A framework is proposed for the design and operation of three-phase direct matrix-type single-stage AC-DC converters for ultrafast (4C) charging of electric two-wheeler and three-wheeler ...